December 2012

Crack GPAT — Prepare for GPAT Online 
PharmaTutor
3 December 2012

TASTE MASKING TECHNOLOGIES: A NOVEL APPROACH FOR THE BETTER PATIENT COMPLIANCE

About Authors:
Dhananjay S. Jadhav
M. Tech (Pharmaceutical Technology) Division of Pharmaceutical Technology,
School of Chemical Technology, North Maharashtra University,
Jalgaon- 425001, India
dhananjaysjadhav@hotmail.com

ABSTRACT
Oral administration of pharmaceuticals is one of the most popular method of drug dilevery.Taste is an important factor in the development of dosage form. “The worse the taste of the medication, the better the cure” was once the prevailing attitude. Many orally administered drugs elicite bitter taste. Undesirable and particularly bitter taste is one of the important formulation problems that are encountered with many drugs. Administration of bitter drugs orally with acceptable level of palatability is a key issue for health care providers. Proven methods for bitterness reduction and inhibition have resulted in improved palatability of oral pharmaceuticals. Several approaches like adding flavors and sweeteners, use of lipoproteins for inhibiting bitterness, coating of drug with inert agents, microencapsulation, multiple emulsion, viscosity modifiers, vesicles and liposomes, prodrug formation, salt formation, formation of inclusion and molecular complexes, solid dispersion system and application of ion exchange resins have been tried by the formulators to mask the unpleasant taste of the bitter drugs. The present review attempts to give a brief account of different technologies of taste masking with respect to dosage form and novel methods of evaluation of taste masking effect.

[adsense:336x280:8701650588]

2 December 2012
Recruitment to the post of Pharmacists- Allopathic, Ayurvedic / Paramedical Staff in ESIC - this ad is cancelled

2 December 2012
Applications invited from M.Pharm/M.Sc for post of JRF, Lab Assistant in POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION & RESEARCH

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage. The institute started in 1962 and Pt Jawahar Lal Nehru inaugurated the hospital now named “Nehru Hospital” on 7th July 1963.

2 December 2012
Opening for Project Assistant Level-II in Department of Pharmacology - PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage. The institute started in 1962 and Pt Jawahar Lal Nehru inaugurated the hospital now named “Nehru Hospital” on 7th July 1963.

2 December 2012
A REVIEW ON APPLICATION OF PHARMACOKINETICS TO CLINICAL SITUATIONS

About Authors:
V. KRISHNA KISHORE
M.Pharm, 2nd Sem (Pharmaceutics)
Roland Institute of  Pharmaceutical Sciences , Berhampur, Odisha.
Krishnakishorev58@gmail.com

1. Abstract:
Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient.
Primary goals of clinical pharmacokinetics include enhancing efficacy and decreasing toxicity of a patient's drug therapy. The development of strong correlations between drug concentrations and their pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to actual patient situations.
A drug's effect is often related to its concentration at the site of action, so it would be useful to monitor this concentration. Receptor sites of drugs are generally inaccessible to our observations or are widely distributed in the body, and therefore direct measurement of drug concentrations at these sites is not practical. For example, the receptor sites for digoxin are believed to be within the myocardium, and we cannot directly sample drug concentration in this tissue. However, we can measure drug concentration in the blood or plasma, urine, saliva, and other easily sampled fluids.

2 December 2012
IMPURITIES AN OVERVIEW

About Authors:
Lila dhar*, Prof. Sanjeev Thacker, Jatin Patel
Seth G. L. Bihani S.D. College Of Technical Education, Institute Of Pharmaceutical Sciences & Drug Research,
Gaganpath, Sri Ganganagar, Rajasthan 335001
*ldbudania@gmail.com

ABSTRACT
Impurities is defined as an entity of drug substances or drug product that is not chemical entity defined as drug substances an excipients or other additives to drug product. In pharmaceutical world, an impurity is generally considered as an other organic material beside the other drug substances that is arises out of the synthesis most of the time, inorganic contaminants are not considered as an impurity unless they are toxic, such as heavy metal or arsenic. There are numerios source of impurities and many different common terms are use for impurities such as by product, intermediate, transformation on product, related product, interaction product and degradation products.

2 December 2012
PhD studentship for JRF in Translational Health Science and Technology Institute - Govt Job

Translational Health Science and Technology Institute (THSTI) is a part of the inter-disciplinary Biotech Science Cluster coming up at Faridabad in the National Capital Region (NCR). The interim laboratories of the Institute are located at Gurgaon in the NCR.

FOR LATEST UPDATES, CLICK TO JOIN AT WHATS APP >>

Add PharmaTutor as preferred source on Google >>

RECOMMENDED POSTS

Recent content